Circle Of Insight Productions
Pharmacology News
Join Dr. Carlos on “Pharmacology Insights,” your source for the latest research and news on pharmacology, medications, and street drugs. Each episode delves into cutting-edge discoveries, practical applications, and the evolving landscape of both legal and illicit substances. Gain a deeper understanding of how drugs work, their impacts on health, and the latest trends in medication and drug use. Tune in for expert analysis and insightful discussions that keep you informed on all things pharmacological.
Bezoek zeker de website van de podcast en steun de maker: www.spreaker.com
Auteur
Circle Of Insight Productions
Categorie
Website van de podcast
Nieuwste aflevering
17 nov. 2026
Waar luisteren?
Podcasts in de app Replaio Radio Binnenkort beschikbaarPodcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts
Afleveringen
CYP450 Drug Interactions: When Psychiatric Medications Change Each Other’s Effects 17.11.2026 4:42
Two psychiatric medications may be safe individually but produce unexpected effects when prescribed together. This episode examines how cytochrome P450 enzymes metabolize psychiatric medications and how inhibitors and inducers alter drug concentrations. We explore fluoxetine, paroxetine, bupropion, carbamazepine, and clozapine, explaining how these interactions influence treatment decisions, adver...
Methamphetamine and the Brain: Dopamine, Psychosis, and Neurotoxicity 16.11.2026 4:04
Explain how methamphetamine affects dopamine transporters, neurotransmitter release, sleep, cognition, and the neural mechanisms associated with addiction and psychosis.
Rhino Tranq: The New Veterinary Sedative Appearing in America’s Fentanyl Supply 15.11.2026 4:58
powerful veterinary sedative known as medetomidine sometimes called “rhino tranq,” is emerging as another dangerous contaminant in the illicit fentanyl supply. More potent than xylazine at alpha-2 adrenergic receptors, medetomidine can cause profound sedation, dangerously slow heart rates, and potentially life-threatening withdrawal. This episode examines its pharmacology, how it differs from trad...
Norepinephrine: The Brain Chemical Behind Focus, Stress, and Psychiatric Medications 09.11.2026 3:35
Norepinephrine plays a central role in attention, motivation, emotional regulation, and the body’s response to stress. This episode explores how disruptions in noradrenergic signaling contribute to ADHD, depression, and anxiety, and why medications such as Strattera (atomoxetine), Effexor (venlafaxine), Cymbalta (duloxetine), and Wellbutrin (bupropion) affect this neurotransmitter in different way...
Why Does One Person Become Addicted to Stimulants While Another Takes Them for ADHD? 08.11.2026 3:32
Two people may take medications that influence the same neurotransmitter systems, yet their psychological and behavioral experiences can be remarkably different. Why do some individuals develop compulsive stimulant use while others experience improved attention, emotional regulation, and everyday functioning? This episode explores the psychology of addiction, reward learning, impulsivity, reinforc...
The Pharmacology of Study Drugs: Amphetamines, Dopamine, and Cognitive Enhancement 02.11.2026 2:50
Explore how amphetamine-based medications influence dopamine and norepinephrine signaling, why subjective concentration can differ from measurable cognitive improvement, and how dose and sleep deprivation influence outcomes.
Withdrawal or Relapse? Why Antidepressant Discontinuation Can Be Misunderstood 01.11.2026 4:04
Explore the psychological and clinical challenges of distinguishing antidepressant discontinuation symptoms from the return of depression or anxiety. Examine how symptom timing, physical sensations, and emotional changes influence clinical assessment, and why a careful medication history is essential.
When Addiction Treatment Becomes Addiction Maintenance: The Pharmacology Behind Rehab Fraud 27.10.2026 2:53
What happens when a facility entrusted with treating substance-use disorders allegedly helps perpetuate the very addiction it promises to address? This episode examines the neurobiology of opioid and stimulant dependence, withdrawal, craving, and the medications used in evidence-based addiction treatment. We explore how access to drugs, inadequate medical supervision, and repeated treatment disrup...
SSRIs Compared: Best Diagnoses, Half-Lives, Side Effects, and Prescribing Exceptions 26.10.2026 5:09
Not every SSRI is interchangeable — choosing the right one depends on far more than just the diagnosis in front of you. This episode compares seven SSRIs across their FDA-approved indications for depression, OCD, panic disorder, and generalized anxiety disorder, breaking down half-lives, side-effect profiles, and the prescribing nuances that separate one agent from another. We cover pediatric and...
Dopamine Blockade: Why Antipsychotics Work and Why They Cause Side Effects 26.10.2026 4:25
Antipsychotic medications frequently act on dopamine D2 receptors, but blocking these receptors produces different effects depending on where they are located in the brain. This episode examines how dopamine antagonism and partial agonism influence psychotic symptoms, movement disorders, and prolactin secretion. We compare first-generation and second-generation antipsychotics, including haloperido...
Why Prozac, Zoloft, and Lexapro Affect Patients Differently 21.10.2026 6:13
Explore pharmacokinetics, CYP450 metabolism, serotonin transporter inhibition, and receptor adaptations. Explain why medications within the same class can differ in tolerability and interaction potential.
Why Antidepressants Take Weeks to Work 20.10.2026 4:35
Explore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant response cannot be reduced to a simple chemical imbalance.
Methamphetamine vs. Adderall: How Different Are They Really? 19.10.2026 4:36
Methamphetamine and prescription amphetamines share important pharmacological properties, but differences in chemical structure, dosing, delivery, and medical supervision can profoundly affect their risks. This episode compares methamphetamine, Adderall, and Ritalin through the lens of neurotransmitter activity and clinical pharmacology. We also explore why methamphetamine itself retains a limited...
Why Antidepressants Take Weeks to Work 18.10.2026 4:35
Explore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant response cannot be reduced to a simple chemical imbalance.
Beyond Fentanyl: The Rise of Synthetic Opioids Ten Times More Potent 15.10.2026 3:29
A new class of synthetic opioids known as orphine analogues has been detected in illicit drug supplies across 22 American states, raising concerns about the next evolution of the opioid crisis. Some of these compounds have demonstrated pharmacological potency substantially greater than fentanyl, while conventional drug screening methods may fail to identify them. We examine how these substances af...
Why Antidepressants Sometimes Stop Working: The Science Behind the Loss of Response 11.10.2026 3:31
Antidepressants influence neurotransmission relatively quickly, yet meaningful clinical improvement often takes longer. This episode explores receptor signaling, neural adaptation, stress circuitry, and neuroplasticity in depression treatment. Discover why changes in brain function are more complicated than the familiar chemical-imbalance explanation.
When Antipsychotics Aren’t the Answer: The Medical Illness That Can Look Like Psychosis 07.10.2026 3:22
Hallucinations, paranoia, agitation, and bizarre behavior can reasonably lead clinicians toward antipsychotic treatment, but what happens when the underlying illness isn’t primarily psychiatric? Anti-NMDA receptor encephalitis can initially resemble a severe psychiatric disorder before neurological symptoms emerge. This episode examines the diagnostic clues that can change the entire treatment str...
Why Do SSRIs Take Weeks to Work If They Change Serotonin Within Hours? 04.10.2026 3:51
SSRIs begin altering serotonin signaling within hours, yet people with depression or anxiety are often told that meaningful improvement may take weeks. Why does the brain respond so slowly if the medication begins working almost immediately? The answer reveals why the familiar idea of antidepressants simply “correcting a chemical imbalance” is far too simplistic. This episode explores serotonin tr...
Beyond the Daily Pill: The Injection Shaking Up Bipolar Treatment 13.09.2026 2:47
A new study published in The American Journal of Psychiatry analyzed electronic health records from 2,086 individuals with bipolar disorder in Hong Kong treated between 2004 and 2023. While long-acting injectable antipsychotics (LAIAs) are already widely recognized for treating schizophrenia, robust comparative guidance for bipolar disorder has historically been limited. The researchers found that...
A Simpler Way to Ease OCD When Bipolar Is Also in the Picture 10.09.2026 2:02
Many people live with both bipolar disorder and obsessive-compulsive symptoms. The usual medicines for OCD can make bipolar moods swing more wildly. A new study points to a different option that may help without that risk.
The FDA Is Fast-Tracking Psychedelics. Noribogaine Is the Test Case That Is Not a Trip. 07.09.2026 2:50
After an executive order pushing HHS to speed mental-health treatments, the FDA issued priority vouchers for psilocybin in depression and methylone in PTSD and cleared the first U.S. trial of an ibogaine-related drug. That compound is noribogaine, aimed at alcohol use disorder, and its developers argue it is not hallucinogenic. The scientific question is no longer whether Washington is interested....
Know Your Brain: The Four Lobes and What They Actually Do 30.08.2026 16:43
This episode breaks down the brain's four primary lobes — frontal, parietal, temporal, and occipital — and explains, in plain terms, what each one actually does and what happens when it's damaged or atypical. Along the way, the conversation touches on how differences in these brain regions show up in conditions like ADHD and autism spectrum disorder. It's a clear, foundational look at neuroanatomy...
Psychopharmacology Masterclass: Drug Classes, Mechanisms of Action, and What Every Psychologist Needs to Know for Clinical Practice and the 24.06.2026 17:12
Psychopharmacology is one of the most heavily tested and clinically consequential domains in professional psychology, covering everything from the neurochemical mechanisms behind antidepressants, antipsychotics, mood stabilizers, and anxiolytics to the pharmacokinetic principles that determine how drugs are absorbed, distributed, metabolized, and eliminated in ways that directly affect treatment o...
Retracted: The Hepatitis B Vaccine, Autism Claims, and the Challenges of Causation 09.06.2026 7:00
In this episode, we examine the recent retraction of a 2010 study that suggested a link between neonatal hepatitis B vaccination and autism in boys. We break down the methodological flaws that led to its withdrawal, explore related research from the same authors and others, and dive into why establishing causal links between vaccines and autism remains extraordinarily complex. Autism is multifacto...
Escitalopram for Kids’ Anxiety: FDA Approval or Risky Gamble? Weighing the Evidence” 08.06.2026 7:53
In 2023, the FDA approved escitalopram (Lexapro) for generalized anxiety disorder (GAD) in children aged 7 and older, based largely on one industry-sponsored trial showing a small statistical edge over placebo on the Pediatric Anxiety Rating Scale (PARS). Critics argue the benefits fall below clinically meaningful thresholds while risks—particularly a roughly six-fold increase in treatment-emergen...
Vergelijkbare podcasts
Replaio is geen uitgever van podcasts; namen van shows, covers en audio zijn eigendom van hun makers en worden verspreid via openbare RSS-feeds